Cargando…
Repurposing of Doramectin as a New Anti-Zika Virus Agent
Zika virus (ZIKV), belonging to the Flavivirus family and mainly transmitted by mosquitoes, causes a variety of adverse outcomes, including Guillain-Barré syndrome, microcephaly, and meningoencephalitis. However, there are no approved vaccines or drugs available for ZIKV. The discovery and research...
Autores principales: | Zhu, Yujia, Liang, Minqi, Yu, Jianchen, Zhang, Bingzhi, Zhu, Ge, Huang, Yun, He, Zhenjian, Yuan, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221537/ https://www.ncbi.nlm.nih.gov/pubmed/37243154 http://dx.doi.org/10.3390/v15051068 |
Ejemplares similares
-
Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
por: Yuan, Jie, et al.
Publicado: (2020) -
Rationally Improving Doramectin Production in Industrial Streptomyces avermitilis Strains
por: Dang, Fujun, et al.
Publicado: (2023) -
Doramectin inhibits glioblastoma cell survival via regulation of autophagy in vitro and in vivo
por: Chen, Chen, et al.
Publicado: (2022) -
Oxidative stress in Strongylus spp. infected donkeys treated with piperazine citrate versus doramectin
por: Elmeligy, Enas, et al.
Publicado: (2021) -
Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
por: Shiryaev, Sergey A., et al.
Publicado: (2017)